Sign in
Not yet recruitingNo phase

Comparison of IV Dexmedetomidine Versus Clonidine Versus no Alpha 2 Agonist on Emergency Delirium, PACU Length of Stay and Time to Hospital Discharge in Children Undergoing (Adeno)Tonsillectomy: a Prospective Observational Study

Key facts

Who runs it
Universitair Ziekenhuis Brussel
Where
Belgium1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
150 people, planned
Starts
1 Dec 2026
Expected to end
31 May 2027
Type of study
Observational, 3 groups
Treatments tested
  • Intravenous dexmedetomidine
  • Intravenous clonidine
  • Standard Anesthetic Care Without Alpha-2 Agonist
Record updated
4 November 2026

Who can take part

Age
2 years to 12 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Children aged 2 to 12 years old
  • Scheduled for elective (adeno)tonsillectomy or tonsillectomy (with or without concurrent myringotomy/tympanostomy tube insertion)
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Surgery performed in an ambulatory / day-surgery setting under general anesthesia
  • Written informed consent provided by parents or legal guardians

Who cannot take part

  • Known hypersensitivity or allergy to clonidine, dexmedetomidine, or other alpha-2 adrenergic agonists
  • Pre-existing severe cardiac conduction abnormalities, severe bradycardia, or hemodynamic instability
  • Severe neurodevelopmental impairment, severe cognitive impairment, or active central nervous system disorders that preclude reliable assessment using the PAED scale
  • Emergency tonsillectomy or active tonsillar hemorrhage
  • Patients requiring planned postoperative intensive care unit (PICU) admission or extended inpatient monitoring
  • Patient or parent/guardian refusal to participate

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 2 and 12 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Emergence delirium (ED) is a frequent complication in children undergoing general anesthesia, particularly following ENT procedures such as adenotonsillectomy. Alpha-2 adrenergic agonists, such as clonidine and dexmedetomidine, are commonly used in pediatric anesthesia for their sedative, analgesic, and ED-reducing properties.The purpose of this prospective observational study (CLONIDEX) is to evaluate and compare the occurrence of emergence delirium, Post-Anesthesia Care Unit (PACU) length of stay, and overall time to hospital discharge in pediatric patients undergoing (adeno)tonsillectomy with or without placement of myringotomy tubes who receive intravenous dexmedetomidine, intravenous clonidine, or no alpha-2 agonist as part of their standard anesthetic care.

The 3 groups in the trial

  • Dexmedetomidine Group

    Pediatric patients undergoing elective (adeno)tonsillectomy with or without placement of myringotomy tubes who receive intraoperative intravenous dexmedetomidine as part of standard anesthetic care, at the discretion of the attending anesthesiologist.

    Treatment: Intravenous dexmedetomidine

  • Clonidine Group

    Pediatric patients undergoing elective (adeno)tonsillectomy with or without placement of myringotomy tubes who receive intraoperative intravenous clonidine as part of standard anesthetic care, at the discretion of the attending anesthesiologist.

    Treatment: Intravenous clonidine

  • Control Group (No Alpha-2 Agonist)

    Pediatric patients undergoing elective (adeno)tonsillectomy with or without placement of myringotomy tubes who do not receive any intraoperative alpha-2 adrenergic agonist (dexmedetomidine or clonidine) as part of standard anesthetic care.

    Treatment: Standard Anesthetic Care Without Alpha-2 Agonist

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Comparison of Intravenously Administered Dexmedetomidine Versus Clonidine Versus No Alpha-2 Agonist on Emergence Delirium, PACU Length of Stay, and Time to Hospital Discharge in Children Undergoing (Adeno)Tonsillectomy: A Prospective Observational Study
Fit questions
Built from NCT07913308, who can take part
Record updated
4 November 2026